There have been few studies evaluating the efficacy of treatments for FSAD (Heiman, 2002). Since the release of Viagra for men in 1998, research into drug treatments for FSAD has focused on finding a similar drug for women. In 2004, the FDA voted not to approve a new product for women called Intrinsa (see Sex in Real Life, “Women and Sexual Dysfunction,” on page 462). Clinical trials of Viagra to treat FSAD have shown that although it can increase vasocongestion and lubrication, it provides little overall benefit in the treatment of female sexual arousal disorder (Basson et al., 2002).
|
Question: Is erectile disorder hereditary?
No, erectile disorder itself is not hereditary. However, certain diseases, such as diabetes, may be inherited and can lead to an erectile disorder or other sexual dysfunctions. It is important to catch these diseases early so that medical intervention can decrease any possible sexual side effects.